Rie Kondo

发表

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2022, Scientific reports.

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Frontiers in Oncology.

Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study

I. Narita, H. Kagamu, T. Kikuchi, 2019, BMC Cancer.

Usefulness of EBUS-TBNA in the Staging of Lung Cancer in Patients with Sarcoidosis and Sarcoid Reactions

Kosuke Ichikawa, T. Kikuchi, Satoshi Watanabe, 2018 .

Prognostic significance of procalcitonin in small cell lung cancer

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

Kazuhiro Sato, Hiroshi Tanaka, Kosuke Ichikawa, 2018, Oncology.

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Cancer Immunology, Immunotherapy.

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2017, PloS one.

Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases

Kazuhiro Sato, T. Ishida, Hiroshi Tanaka, 2019, Thoracic cancer.

Recurrent Interstitial Lung Disease Induced By Various Therapies forNon-Small Cell Lung Cancer

I. Narita, Hiroshi Tanaka, H. Kagamu, 2014 .

TNF-&agr; production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis

Y. Yatomi, H. Tsutsui, M. Satoh, 2014, Coronary artery disease.

Cooperation of NF-κB2/p100 Activation and the PDZ Domain Binding Motif Signal in Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax1 but Not HTLV-2 Tax2 Is Crucial for Interleukin-2-Independent Growth Transformation of a T-Cell Line

M. Matsuoka, Yuetsu Tanaka, R. Mahieux, 2007, Journal of Virology.

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

after Lymphodepleting Chemotherapy Regulatory T Cells in Antitumor Immunity Critical Roles of Chemoresistant Effector and

K. Nakata, Daisuke Ishikawa, Kosuke Ichikawa, 2015 .

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Translational lung cancer research.

Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy

Kazuhiro Sato, T. Ishida, Hiroshi Tanaka, 2020, Cancer medicine.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2021, Scientific reports.

Henoch Schönlein purpura associated with pulmonary adenocarcinoma

I. Narita, H. Kagamu, Satoshi Watanabe, 2011, Journal of medical case reports.

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations

Y. Ajioka, Hiroshi Tanaka, Miyuki Sato, 2019, PloS one.

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Scientific Reports.

DDX3X mediates EGFR-TKI resistance through VEGFR signaling

Takaaki Masuda, T. Sekiya, Aya Ohtsubo, 2021 .

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Rie Kondo, Junko Baba, Hiroshi Kagamu, 2011, BMC Cancer.

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

I. Narita, Daisuke Ishikawa, Aya Ohtsubo, 2016, BMC Cancer.

Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2

Yuetsu Tanaka, M. Higuchi, T. Shoji, 2009, Retrovirology.

Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line

Yuetsu Tanaka, M. Higuchi, Masahiko Takahashi, 2006, Retrovirology.

Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.

M. Matsuoka, Yuetsu Tanaka, R. Mahieux, 2007, Journal of virology.

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

I. Narita, Daisuke Ishikawa, Aya Ohtsubo, 2016, BMC Cancer.